Posts by VIVA! Communications
A look back at the health trends of 2017
2017 was another year where Australians continued to rely on search engines to query their health problems and learn more about trends in the comfort of their own home. VIVA! Communications has taken a look back on the year and put together our top five trends. Topping the list was the keto diet, a high-fat,…
Read MoreHappy Holidays From GLOBALHealthPR
Traditionally, GLOBALHealthPR shares some of our favourite holiday traditions from our partners around the world. This year, we decided to share a holiday card…..about holiday cards. Each card below carries with it a taste of the culture from our partner agencies around the world, and greeting for a joyous and prosperous new year. From all…
Read MoreVictorian Young Adults roll-your-own cigarette use on the rise – December 18, 2017
Young smokers’ in Victoria believe roll-your-own cigarettes are less harmful than traditional factory made cigarettes, according to statistics released today (December 18, 2017). The Victorian Smoking and Health Survey, commissioned by Cancer Council Victoria and Quit Victoria, involved 4,000 adult smokers and revealed the startling figures that roll-your own tobacco use had increased in recent…
Read MoreDifference between physiotherapy and chiropractic
The majority of people will experience some kind of neck pain, back pain or other musculoskeletal injury at some point throughout their lives. Whether this be a sporting injury, as a result of a car accident or simply from general wear and tear of the joints and muscles in our body, most people who seek…
Read MoreAustralian developed, first-in-class rheumatoid arthritis medication secures green-light for human trials in Brisbane
Australia’s first in-human study of a first-in-class rheumatoid arthritis immunotherapy treatment developed by University of Queensland researchers was launched on November 14, 2017. The Phase 1, double-blind, placebo-controlled study currently underway at Brisbane’s Princess Alexandra Hospital, will consider both single-ascending dose, and multi-dose protocols to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous (under…
Read More